Apexigen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Apexigen and buy or sell other stocks, ETFs, and their options commission-free!About APGN
Brookline Capital Acquisition Corp. is a blank check company which intends to focus its search on companies in the life sciences industry. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities.
CEOSam P. Wertheimer, PhD
CEOSam P. Wertheimer, PhD
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded
Founded
Employees—
Employees—
APGN Key Statistics
Market cap9.57M
Market cap9.57M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume21.02K
Average volume21.02K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.28
52 Week high$8.28
52 Week low$0.3305
52 Week low$0.3305
Stock Snapshot
Apexigen(APGN) stock is priced at $0.39, giving the company a market capitalization of 9.57M.
On 2025-11-15, Apexigen(APGN) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 21.02K.
The stock's 52-week range extends from a low of $0.33 to a high of $8.28.
The stock's 52-week range extends from a low of $0.33 to a high of $8.28.
People also own
Based on the portfolios of people who own APGN. This list is generated using Robinhood data, and it’s not a recommendation.